Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in children and young adults with MS
NCT04121468Phase 2Recruiting
- Sponsor
- SickKids
- Start
- Feb 2020
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of liquid metformin (Aspargo Labs) in multiple sclerosis (MS) (3 arms), sponsored by SickKids. Primary endpoints: Number of patients with adverse events at 3 years, Number of patients who were approached to participate, declined participation and consented to participate at 3 years and 3 more. Started Feb 2020; status: recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT04121468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04121468.